Gordon L. Amidon

ORCID: 0000-0003-0355-911X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Drug Solubulity and Delivery Systems
  • Drug Transport and Resistance Mechanisms
  • Analytical Chemistry and Chromatography
  • Advanced Drug Delivery Systems
  • Analytical Methods in Pharmaceuticals
  • Crystallization and Solubility Studies
  • Gastrointestinal motility and disorders
  • Pharmaceutical studies and practices
  • HIV/AIDS drug development and treatment
  • Amino Acid Enzymes and Metabolism
  • Antibiotics Pharmacokinetics and Efficacy
  • Pharmacological Effects and Toxicity Studies
  • Gastroesophageal reflux and treatments
  • Neuropeptides and Animal Physiology
  • Pharmacogenetics and Drug Metabolism
  • Peptidase Inhibition and Analysis
  • Biochemical and Molecular Research
  • RNA Interference and Gene Delivery
  • Protein purification and stability
  • Chemical Synthesis and Analysis
  • Chemical and Physical Properties in Aqueous Solutions
  • Computational Drug Discovery Methods
  • Adenosine and Purinergic Signaling
  • Helicobacter pylori-related gastroenterology studies
  • HIV Research and Treatment

University of Michigan
2015-2024

Michigan United
2012-2020

Target (United States)
2008-2011

Center for Drug Evaluation and Research
2003-2010

Setsunan University
2006-2010

Ben-Gurion University of the Negev
2010

Yale University
2010

Therapeutics Systems Research Laboratories (United States)
1994-2008

Michigan Center for Translational Pathology
2008

Universitat de València
2003-2006

The purpose of this study is to provisionally classify, based on the Biopharmaceutics Classification System (BCS), drugs in immediate-release dosage forms that appear World Health Organization (WHO) Essential Drug List. classification report aqueous solubility reported commonly available reference literature and a correlation human intestinal membrane permeability for set 29 with their calculated partition coefficients. WHO List consists total 325 medicines 260 drugs, which 123 are oral (IR)...

10.1021/mp034006h article EN Molecular Pharmaceutics 2003-12-17

Orally administered, immediate-release (IR) drug products in the top 200 product lists from United States (US), Great Britain (GB), Spain (ES), and Japan (JP) were provisionally classified based on Biopharmaceutics Classification System (BCS). The provisional classification is aqueous solubility of drugs reported readily available reference literature a correlation human intestinal membrane permeability for set 29 with their calculated partition coefficients. Oral IR constituted more that...

10.1021/mp0600182 article EN Molecular Pharmaceutics 2006-10-03

10.1016/s0378-5173(99)00147-7 article EN International Journal of Pharmaceutics 1999-09-20

The rate and extent of drug dissolution absorption from solid oral dosage forms is highly dependent upon the volumes distribution gastric small intestinal water. However, little known about time courses water in vivo an undisturbed gut. Previous imaging studies offered a snapshot fasted humans showed that intestine distributed pockets. This study aimed to quantify volume number pockets upper gut healthy following ingestion glass (240 mL, as recommended for bioavailability/bioequivalence...

10.1021/mp500210c article EN cc-by Molecular Pharmaceutics 2014-08-12
Coming Soon ...